← Back to Clinical Trials
Recruiting NCT07298070

NCT07298070 Functional and Aesthetic Outcomes Following Lower Lip Reconstruction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07298070
Status Recruiting
Phase
Sponsor Hôpital NOVO
Condition Lower Lip Tissue Loss
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2026-04-21
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Patient-Reported Outcome Questionnaire (post-operative)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2026-04-21 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This retrospective study, aims to evaluate the functional and aesthetic results of lower lip reconstructions, incorporating both patient experiences and the analysis of physicians and surgeons working on facial issues (plastic surgeons and dermatologists) in order to optimize future therapeutic strategies.

Eligibility Criteria

Inclusion Criteria: * Patient over 18 years of age. * Patients who underwent lower lip reconstruction after excision for skin carcinoma, operated on in Pontoise between January 1, 2014, and October 31, 2025. * Patients who had a post-operative follow-up consultation (± 2 months). * Patients who were informed and did not object to participating in the study Exclusion Criteria: * Cognitive impairment preventing completion of the questionnaire. * Patient under legal protection (guardianship, conservatorship, or judicial protection). * Patient deceased.

Contact & Investigator

Central Contact

Maryline Delattre

✉ maryline.delattre@ght-novo.fr

📞 0033130754131

Principal Investigator

AL TABAA AL TABAA, Dr

PRINCIPAL INVESTIGATOR

Hôpital NOVO - Site Pontoise

Frequently Asked Questions

Who can join the NCT07298070 clinical trial?

This trial is open to participants of all sexes, studying Lower Lip Tissue Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07298070 currently recruiting?

Yes, NCT07298070 is actively recruiting participants. Contact the research team at maryline.delattre@ght-novo.fr for enrollment information.

Where is the NCT07298070 trial being conducted?

This trial is being conducted at Cergy-Pontoise, France.

Who is sponsoring the NCT07298070 clinical trial?

NCT07298070 is sponsored by Hôpital NOVO. The principal investigator is AL TABAA AL TABAA, Dr at Hôpital NOVO - Site Pontoise. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology